Lb Pharmaceuticals (LBRX) Free Cash Flow (2024 - 2026)

Lb Pharmaceuticals' Free Cash Flow history runs 3 years deep, the most recent figure standing at -$23.3 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 186.19% year-over-year to -$23.3 million; the TTM figure through Mar 2026 stood at -$49.6 million (changed N/A YoY), while the FY2025 annual figure was -$35.3 million, up 34.5% from the prior year.
• Free Cash Flow was -$23.3 million for Q1 2026 at Lb Pharmaceuticals, down from -$18.1 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$5.9 million in Q4 2024 to a low of -$23.3 million in Q1 2026.
• Historically, Free Cash Flow has averaged -$13.9 million across 3 years, with a median of -$13.1 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Free Cash Flow plunged 207.3% in 2025, then plunged 186.19% in 2026.
• A 3-year view of Free Cash Flow shows it stood at -$5.9 million in 2024, then slumped by 207.3% to -$18.1 million in 2025, then declined by 28.57% to -$23.3 million in 2026.
• The last three Free Cash Flow figures came in at -$23.3 million (Q1 2026), -$18.1 million (Q4 2025), and -$8.1 million (Q1 2025), per Business Quant data.